For reasons that are unclear, patients with dermatitis herpetiformis (DH) have a lower than expected mortality rate from ischaemic heart disease. We have compared risk factors for ischaemic heart disease (lipids, fibrinogen levels, smoking history and social class) in 29 DH patients and 57 controls matched for age and sex.
INTRODUCTION
Dermatitis herpetiformis (DH) is an uncommon blistering skin disease of unknown aetiology, characterized by granular IgA deposits in the basement membrane zone of the skinl. Importantly, gluten enteropathy is present in almost 100% of patients after gluten loading24. Because the enteropathy is usually mild, overt malabsorption is rare5. The origin of the cutaneous IgA deposits is unknown but may reflect a response to dietary antigen; alternatively, abnormalities may allow an unknown antigen access to the central immune systeml. A previous study indicated that patients with DH have a lower mortality rate from ischaemic heart disease than expected from national ratess. Low lipid concentrations due to malabsorption, genetic predisposition and smoking were suggested as possible mechanisms. The main risk factors for coronary heart disease include hyperlipidaemia, hypertension, smoking, diabetes mellitus and hyperfibrinogenaemia6. Family history of ischaemic heart disease is also important; and low socioeconomic status is a stronger risk factor in women than in men7. The apolipoprotein a (Apo a) and apolipoprotein B (Apo B), the main component of LDL. It is structurally related to plasminogen and an independent cardiovascular risk factor. This complex has an unknown physiological role8 but raised Lp (a) concentrations are associated with increased risk of atheroma9. There have been no studies on the prevalence of risk factors for coronary heart disease in patients with DH. We have assessed known risk factors, especially lipids and apolipoproteins, social class and smoking history, in DH patients and controls.
METHODS

Patient selection
29 patients were identified from hospital records, only those with histological and direct immunofluorescence findings compatible with a diagnosis of DH being included in the study. Patients were interviewed and completed a questionnaire including age, sex, smoking history allowing determination of number of pack years smoked (1 pack year=20 cigarettes a day for 1 year), family history of ischaemic heart disease (defined as more than one family member affected below the age of 45 years), family history of DH or coeliac disease, history of hypertension, diabetes mellitus, ischaemic heart disease or hyperlipidaemia, occupation, treatment and previous evidence of malabsorption. Social class was determined from the Office of Population Censuses and Surveys classification of occupations document 198010. The controls were age and sex matched caucasian, non-obese, healthy individuals with atopic eczema and individuals undergoing routine general health screening in general practitioner clinics (n=57). No controls had a history of diabetes mellitus. DH is rare and we collected more controls than cases to increase the power of the study. No patients or controls were on antihypertensive medication or aspirin at the time of the study. Urine analysis was negative for sugar in all cases.
Lipid measurement
Fasting serum samples were available from 19 patients and 57 controls. The procedure for fasting was the same in patients and controls. The following fractions were measured: total cholesterol and HDL3 cholesterol; triglycerides; apo Al; apo B and Lp (a). HDL2 and LDL were calculated from the measured indices. Fibrinogen concentrations were also determined from fasting plasma.
Statistical analysis
For non-skewed data (total cholesterol, HDL, apo Al, apo B and fibrinogen), a t test was used to analyse any differences. For skewed data (triglycerides, HDL3, HDL2, LDL and Lp (a)), we used the Mann-Whitney U test and for pack-year smoking data a Wilcoxon sign rank matchedpair test. The Statxact-Turbo package was used for a marginal homogeneity test to analyse the social class results. This test is a generalization of the McNemar test from a binomial response to a multinomial response. Table 1 lists the characteristics of the 29 patients with DH. 20 were men and 9 women, average age 59.1 years (SD 14.12). The average age of the 57 controls was 59.3 years (SD 14.15). 20 patients had received dapsone at some point in their disease. 22 had followed a gluten-free diet and 18 were doing so at the time of the study. 6 of 8 patients endoscoped had villous atrophy on biopsy. Lipid fractions Table 2 records lipid fractions in cases and controls. Patients with DH had a more advantageous lipid profile with lower total cholesterol, triglycerides, LDL and apo B and higher HDL and HDL2. There was no significant difference in Lp (a) and apo Al. There were no significant differences in lipids between those on a gluten-free diet and those on dapsone or in those seen to have villous atrophy, although the numbers for these comparisons were small. Patients with DH had lower fibrinogen levels than controls.
RESULTS
Other risk factors Patients with DH smoked less (median difference 10 pack years) and were of a higher social class (median difference 1 social class). There were no significant differences between cases and controls in family history of ischaemic heart disease or history of hypertension, hyperlipidaemia, angina or diabetes mellitus.
DISCUSSION
The observation that patients with DH have a more favourable lipid profile, smoke less and are of higher social class than controls might account for their lower mortality rate from ischaemic heart disease. It would be useful to corroborate the findings in a larger cohort. How might the difference in lipid profile arise? Intestinal villous atrophy may be an important factor, since some of the lipid particles, particularly LDL, are synthesized in the gut1l.
Another possibility is that the more advantageous lipid profile is due to a gluten-free diet. Both these hypotheses need to be explored in larger series. In one study of patients with coeliac disease, a gluten-free diet did increase the HDL and decrease the triglycerides1 2; if this is so in DH, it would favour the use of a gluten-free diet rather than dapsone. However, in another study in severe coeliac disease, normalization of faecal steroid excretion with a gluten-free diet suggested that cholesterol malabsorption is due to mucosal damage'3. Many patients with DH have been referred to a dietitian and it is possible that, even if not following a gluten-free diet, they will have received and followed good general dietary advice, with consequent advantages to their lipid profile. Patients with DH also had lower fibrinogen levels than controls. Although an independent risk factor for ischaemic heart disease, fibrinogen is believed to be a secondary marker of the degree of atheroma14; thus the DH patients may have less atheroma than controls.
We found, unexpectedly, that DH patients were of a higher social class and smoked less than controls. There is no absolute definition of social class and all methods of determining it are open to criticism especially with regard to female classification. We based our assessment on occupation. The explanation underlying these observations is unclear. It may be associated with another as yet unknown factor. One possibility, though implausible, is that high social classes are more apt to consume an antigen associated with DH development; another is that they are more likely to consult a dermatologist (though the rash in DH is usually very troublesome and most patients would seek medical attention for it). Similarly, we can only speculate on why patients with DH smoke less than controls. It may be an association with social class or be an effect of receiving counselling and general health advice from dietitians. In DH, gluten enteropathy is present in almost 100% of patients after gluten loading, thus coeliac disease and DH may be part of a spectrum of disease2A4. Lately it has been observed that cigarette smoking seems to exert a protective effect against the development of adult coeliac disease15. Smoking has immunomodulatory effects including suppression of natural killer lymphocytes16 and a reduction of IgA concentrations in intestinal secretions17. These effects may help to protect against DH and coeliac disease.
